Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2008
09/12/2008WO2008109560A2 Amelioration of cellular stress response
09/12/2008WO2008109459A1 Luciferins
09/12/2008WO2008109440A2 Predicting response to a her dimerisation inhibitor based on low her3 expression
09/12/2008WO2008109332A2 Methods and compositions for determining the efficacy of breast cancer therapeutics
09/12/2008WO2008109274A1 Nell-1 enhanced bone mineralization
09/12/2008WO2008109183A1 Approach for passively detecting analytes
09/12/2008WO2008109161A2 Deeply quenched enzyme sensors
09/12/2008WO2008109057A1 Organic compounds and their uses
09/12/2008WO2008109030A2 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
09/12/2008WO2008108994A1 Trp/his exchange and kynurenine induced trp transport
09/12/2008WO2008108803A2 Immune cell biosensors and methods of using same
09/12/2008WO2008108794A2 Controlling dendritic cell maturation state in the lymphoid tissue equivalent of an artificial immune system
09/12/2008WO2008108723A1 Diagnosis of collagen ix destruction
09/12/2008WO2008108714A1 Interactive alcometry
09/12/2008WO2008108689A2 Mix for identification test in the process of quality control of the medicine 'glycine tablets for sublingual applying 0,1g' methods of its preparation and identity evaluation in the process of quality control of the aforementioned medicine
09/12/2008WO2008108510A1 Diagnostic kit for leptospirosis
09/12/2008WO2008108481A1 Flow control mechanism for microchip
09/12/2008WO2008108470A1 Method of evaluating foam-holding properties of fermented malt drink and marker for evaluating foam-holding properties
09/12/2008WO2008108440A1 Method for measurement of stress level in mammal and measurement tool for use in the method
09/12/2008WO2008108410A1 Method of producing tissue array block, method of producing tissue array sheet, tissue array block, tissue array chip, system of producing tissue array block and system of producing tissue array sheet
09/12/2008WO2008108385A1 Method for measurement of glycosylated hexapeptide
09/12/2008WO2008108257A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
09/12/2008WO2008108074A1 Fluorescent probe
09/12/2008WO2008108059A1 Breast cancer pathologic image diagnosis supporting system, breast cancer pathologic image diagnosis supporting method, beast cancer pathologic image diagnosis supporting program, and recording medium in which brest cancer pathologic image diagnosis supporting program is recorded
09/12/2008WO2008108007A1 Method of assaying protein in sample and assay reagent therefor
09/12/2008WO2008107912A2 In vitro assay methods for classifying embryotoxicity of compounds
09/12/2008WO2008107864A1 Diagnosing breast cancer by seprase level
09/12/2008WO2008107847A1 Magnetic sensor device
09/12/2008WO2008107724A2 Stabilisation of biological cell markers
09/12/2008WO2008107711A1 Partially-methylated break light assay for dna methyltransferase activity
09/12/2008WO2008107701A1 Diagnosing psychotic disorders
09/12/2008WO2008107700A1 Diagnosing psychotic disorders
09/12/2008WO2008107699A1 Diagnosing psychotic disorders
09/12/2008WO2008107691A1 Methods and apparatus for particle detection
09/12/2008WO2008107651A1 Sensor
09/12/2008WO2008107649A1 Sensor
09/12/2008WO2008107572A1 Digalactolipidic antigen exposed on the surface of apicomplex parasites, and diagnostic and therapeutic use thereof
09/12/2008WO2008107523A2 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
09/12/2008WO2008107522A1 Novel acidic glycan markers of human cells
09/12/2008WO2008107508A1 Use of snail1 activity inhibiting compounds in the preparation of pharmaceutical compositions intended for the treatment of chondrodystrophies, method for identifying inhibiting compounds, pharmaceutical compositions, chondrodystrophy diagnosis method and applications thereof
09/12/2008WO2008107477A1 Method of analysing the hydrocarbon compounds in a bituminous material
09/12/2008WO2008107476A1 Method for the standardization of the concentration of analytes in a urine sample
09/12/2008WO2008107422A1 Osteopontin for the prediction and treatment of cardiovascular diseases
09/12/2008WO2008107271A1 Imprinted polymers
09/12/2008WO2008107203A1 Biochip, and method for the selective identification of chlamydia trachomatis infections
09/12/2008WO2008107201A1 Use of slim-1 in the assessment of heart failure
09/12/2008WO2008107174A1 Method for determining the amount of conjugated taxane in polyglut acid-taxane conjugates
09/12/2008WO2008106986A1 Pig model for psoriasis
09/12/2008WO2008106938A2 Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for nyha i patients
09/12/2008WO2008106796A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity
09/12/2008WO2008106785A1 Assessment of risk for colorectal cancer
09/12/2008WO2008106782A1 Serial siphon valves for fluidic or microfluidic devices
09/12/2008WO2008106730A1 Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents
09/12/2008WO2008106709A1 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
09/12/2008WO2008106707A1 Method of determining nt-probnp
09/12/2008WO2008089831A3 G-protein coupled receptor 83 as a molecular switch for the induction of regulatory (immunosuppressive) t-cells
09/12/2008WO2008083323A9 Detection apparatus
09/12/2008WO2008076406A8 Methods and apparatus for measuring analytes using large scale fet arrays
09/12/2008WO2008074935A3 Biologically active compositions, methods for producing the same and biological applications
09/12/2008WO2008074851A3 Method for inhibiting the expression of endogenous erythropoietin (epo)
09/12/2008WO2008074315A3 Diagnosis and risk stratification by means of the novel marker ct-proadm
09/12/2008WO2008073939A3 Stimulus indicating device employing polymer gels
09/12/2008WO2008072242A3 Compositions and methods for concentrating and depleting microorganisms
09/12/2008WO2008070237A3 Immunoassay reagents, processes, and kits
09/12/2008WO2008068422A3 Cosmetic use of a protein belonging to the ribonuclease family<0}
09/12/2008WO2008067103A9 Magnetically susceptible particles and apparatuses for mixing the same
09/12/2008WO2008063996A3 Therapeutic targeting of escort proteins
09/12/2008WO2008063928A3 Proteomic analysis of cervical-vaginal fluids for detecting intra-uterine infection or determining pre-term delivery risk in a pregnant female
09/12/2008WO2008057366A3 Binding surfaces for affinity assays
09/12/2008WO2008057172A3 Organic compounds
09/12/2008WO2008056290A9 Use of arylboronic acids in protein labelling
09/12/2008WO2008055153A9 Gene reporter assay, kit and cells with improved sensitivity and/or specificity for determining the level of an extracellular signal
09/12/2008WO2008054881A9 Antibacterial and plasmid elimination agents
09/12/2008WO2008051660A3 Apparatus and method for computer modeling chemical sensitivity of skin
09/12/2008WO2008036060A3 Clostridial toxin activity assays
09/12/2008WO2008018853A3 Chemical warfare agent (cwa) and toxic industrial chemical (tic) detection by degradation combined with acid-base indicator dyes
09/12/2008WO2007121465B1 Detection of proteins from circulating neoplastic cells
09/12/2008WO2007111657A3 Method for diagnosing rheumatoid arthritis via assaying myofibroblast-like synoviocytes for fibroblast activation protein
09/12/2008WO2007089945A3 Treating diseases by targeting silt3
09/12/2008WO2007078297A8 Luminescent metal oxide films
09/12/2008CA2717680A1 Novel acidic glycan markers of human cells
09/12/2008CA2715856A1 Pig model for psoriasis
09/12/2008CA2680339A1 Use of slim-1 in the assessment of heart failure
09/12/2008CA2680254A1 Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of hepatic cells
09/12/2008CA2680198A1 Process for normalizing the concentration of analytes in a urine sample
09/12/2008CA2680168A1 Determining foam-holding properties of a fermented malt drink based on protein z7
09/12/2008CA2680123A1 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
09/12/2008CA2680073A1 Method for determining the amount of conjugated taxane in polyglutamic acid-taxane conjugates
09/12/2008CA2680058A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity
09/12/2008CA2679954A1 Assessment of risk for colorectal cancer
09/12/2008CA2679943A1 Multigene assay to predict outcome in an individual with glioblastoma
09/12/2008CA2679834A1 Procurement, isolation and cryopreservation of endometrial/menstrual cells
09/12/2008CA2679723A1 Nell-1 enhanced bone mineralization
09/12/2008CA2679664A1 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
09/12/2008CA2679545A1 Osteopontin for the prediction and treatment of cardiovascular diseases
09/12/2008CA2679395A1 Serial siphon valves for fluidic or microfluidic devices
09/12/2008CA2679393A1 Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents
09/12/2008CA2679321A1 Diagnosis of collagen ix destruction
09/12/2008CA2679045A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
09/12/2008CA2678555A1 Amelioration of cellular stress response
1 ... 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 ... 3937